News summary

Shanghai pharmaceuticalcrouchingtigerhiddendragoniithegreendestiny2016: New specifications of parecoxib sodium for injection received approval number Securities Times e Company News, Shanghai Pharmaceutical (601607) announced on the evening of April 30. Recently, the company's wholly-owned subsidiary Shangyao Dongying (Jiangsu) Pharmaceutical Co., Ltd.crouchingtigerhiddendragoniithegreendestiny2016parecoxib sodium for injection received from the State Food and Drug Administrationcrouchingtigerhiddendragoniithegreendestiny2016.crouchingtigerhiddendragoniithegreendestiny2016..

Newsletter text

Shanghai Pharmaceutical: The new specification of parecoxib sodium for injection received approval number Securities Times e Company News, Shanghai Pharmaceutical (601607) announced on the evening of April 30 that recently, the company's wholly-owned subsidiary Shangyao Dongying (Jiangsu) Pharmaceutical Co., Ltd. The company's parecoxib sodium for injection received the "Drug Supplement Application Approval Notice" issued by the State Food and Drug Administration, and the new specification of 40mg of the drug was approved.